"Sontra Medical Looks Healthier With Bayer" (Inside Wall Street, Oct. 13, 2003)
Sean Moran, chief financial officer of Sontra Medical, says Sontra's SonoPrep product will be marketed in 2004 for topical lidocaine delivery, not for glucose testing "Sontra Medical looks healthier with Bayer," (Inside Wall Street, Oct. 13.) The glucose-testing product will be marketed in late 2006 or early 2007. The Ammon twins will inherit approximately $15 million, according to Generosa Ammon Pelosi's July, 2003, will -- not $25 million, as reported in "A murder mystery, a money mess" (Finance, Oct. 20).